Showing results (221-230 of 516) with videos related to

Sort By:
Pageof 52
Prostate Cancer|November 24, 2011
Prostate intrafraction translation margins for real-time monitoring and correction strategiesDale W Litzenberg, James M Balter, Scott W Hadley, et al.
The Lancet. Oncology|September 21, 2007
COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trialLi-Yan Khor, Kyounghwa Bae, Alan Pollack, et al.
The British Journal of Ophthalmology|December 8, 2009
Long-term response to fractionated radiotherapy of presumed optic nerve sheath meningiomaRobert L Lesser, Jonathan P S Knisely, Silas L Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|January 28, 2017
Effect of Long-Term Hormonal Therapy (vs Short-Term Hormonal Therapy): A Secondary Analysis of Intermediate-Risk Prostate Cancer Patients Treated on NRG Oncology RTOG 9202Amin J Mirhadi, Qiang Zhang, Gerald E Hanks, et al.
Practical Radiation Oncology|March 17, 2024
Practical Considerations for the Treatment of an Adrenal Metastasis With Stereotactic Body Radiation TherapyJames B Yu, David J Grew, Erin Sculley, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2003
Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA eraDeborah A Kuban, Howard D Thames, Larry B Levy, et al.
Cancer|September 1, 2006
Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone: a multiinstitutional pooled analysisEric M Horwitz, Lawrence B Levy, Howard D Thames, et al.
International Journal of Radiation Oncology, Biology, Physics|April 10, 2007
Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapyMary Feng, Alexandra L Hanlon, Thomas M Pisansky, et al.
American Journal of Clinical Oncology|August 25, 2021
Outcomes of Stereotactic Radiosurgery and Immunotherapy in Renal Cell Carcinoma Patients With Brain MetastasesHaruka Uezono, David Nam, Harriet M Kluger, et al.
Cureus|May 29, 2018
Long-term Quality of Life in Survivors of Brain Metastases: A Roller Coaster of PerspectiveNaveen Kumar Reddy, Franklin C Brown, Miklos C Fogarasi, et al.
Pageof 52